重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2013年
28期
3347-3349
,共3页
王妍%徐酉华%胡艳妮%孙艳辉%金鑫%杨桂存
王妍%徐酉華%鬍豔妮%孫豔輝%金鑫%楊桂存
왕연%서유화%호염니%손염휘%금흠%양계존
GSK-3β%PTEN%PLK1%前体细胞淋巴母细胞白血病淋巴瘤
GSK-3β%PTEN%PLK1%前體細胞淋巴母細胞白血病淋巴瘤
GSK-3β%PTEN%PLK1%전체세포림파모세포백혈병림파류
GSK-3β%PTEN%PLK1%precursor cell lymphoblastic leukemia-lymphoma
目的:探讨糖原合酶激酶-3β(GSK-3β)、与张力蛋白同源的位于第10号染色体磷酸酶基因(PT EN )、Polo样激酶1(PLK1)在儿童急性髓系白血病(AML)中的表达及意义。方法 RT-PCR方法检测实验组(33例初诊AML患儿的骨髓)和对照组(10例正常骨髓)骨髓单个核细胞(BMMNC)中GSK-3βmRNA、PTEN mRNA、PLK1 mRNA的表达,ELISA方法检测GSK-3β蛋白及P-GSK-3β的表达。结果实验组中GSK-3β mRNA、GSK-3β蛋白、PLK1 mRNA的表达量高于对照组(P=0.012;P=0.014;P=0.040);PTEN mRNA、P-GSK-3β的表达量低于对照组(P=0.012;P=0.002)。GSK3β蛋白与 PTEN mRNA的表达呈负相关(r=-0.415,P=0.016);GSK-3βmRNA、GSK3β蛋白与 PLK1 mRNA的表达成呈正相关(r=0.388,P=0.026;r=0.427,P=0.013)。外周血白细胞计数增高者GSK-3β蛋白表达增高;临床危险度高者GSK-3β mRNA、GSK-3β蛋白的表达增高,P-GSK-3β的表达降低。结论在儿童AML中,GSK-3β和PLK1可能起癌基因的作用,PTEN可能起抑癌基因的作用。
目的:探討糖原閤酶激酶-3β(GSK-3β)、與張力蛋白同源的位于第10號染色體燐痠酶基因(PT EN )、Polo樣激酶1(PLK1)在兒童急性髓繫白血病(AML)中的錶達及意義。方法 RT-PCR方法檢測實驗組(33例初診AML患兒的骨髓)和對照組(10例正常骨髓)骨髓單箇覈細胞(BMMNC)中GSK-3βmRNA、PTEN mRNA、PLK1 mRNA的錶達,ELISA方法檢測GSK-3β蛋白及P-GSK-3β的錶達。結果實驗組中GSK-3β mRNA、GSK-3β蛋白、PLK1 mRNA的錶達量高于對照組(P=0.012;P=0.014;P=0.040);PTEN mRNA、P-GSK-3β的錶達量低于對照組(P=0.012;P=0.002)。GSK3β蛋白與 PTEN mRNA的錶達呈負相關(r=-0.415,P=0.016);GSK-3βmRNA、GSK3β蛋白與 PLK1 mRNA的錶達成呈正相關(r=0.388,P=0.026;r=0.427,P=0.013)。外週血白細胞計數增高者GSK-3β蛋白錶達增高;臨床危險度高者GSK-3β mRNA、GSK-3β蛋白的錶達增高,P-GSK-3β的錶達降低。結論在兒童AML中,GSK-3β和PLK1可能起癌基因的作用,PTEN可能起抑癌基因的作用。
목적:탐토당원합매격매-3β(GSK-3β)、여장력단백동원적위우제10호염색체린산매기인(PT EN )、Polo양격매1(PLK1)재인동급성수계백혈병(AML)중적표체급의의。방법 RT-PCR방법검측실험조(33례초진AML환인적골수)화대조조(10례정상골수)골수단개핵세포(BMMNC)중GSK-3βmRNA、PTEN mRNA、PLK1 mRNA적표체,ELISA방법검측GSK-3β단백급P-GSK-3β적표체。결과실험조중GSK-3β mRNA、GSK-3β단백、PLK1 mRNA적표체량고우대조조(P=0.012;P=0.014;P=0.040);PTEN mRNA、P-GSK-3β적표체량저우대조조(P=0.012;P=0.002)。GSK3β단백여 PTEN mRNA적표체정부상관(r=-0.415,P=0.016);GSK-3βmRNA、GSK3β단백여 PLK1 mRNA적표체성정정상관(r=0.388,P=0.026;r=0.427,P=0.013)。외주혈백세포계수증고자GSK-3β단백표체증고;림상위험도고자GSK-3β mRNA、GSK-3β단백적표체증고,P-GSK-3β적표체강저。결론재인동AML중,GSK-3β화PLK1가능기암기인적작용,PTEN가능기억암기인적작용。
Objective To explore the expression and clinical significance of GSK-3β,PTEN and PLK1 in pediatric AML . Methods Experiment group was bone marrows of 33 cases incipient children with AML .Control group was 10 cases normal bone marrows .GSK-3β,PTEN and PLK1 gene expressions in BMMNC of the two groups were tested using semi quantitative reverse transcriptase polymerase chain reaction(RT-PCR)technique .GSK-3βprotein and P-GSK-3βexpressions were tested by ELISA .Re-sults The expression of GSK-3βmRNA ,GSK-3βprotein ,PLK1 mRNA in BMMNC of children with AML was higher than that of control group(P=0 .012 ;P= 0 .014 ;P= 0 .040);The expression of PTEN mRNA ,P-GSK-3β was lower than the control group (P=0 .012 ;P=0 .002);GSK-3βprotein had a negative correlation with PTEN mRNA (r= -0 .415 ,P=0 .016);GSK-3βmRNA , GSK-3βprotein had a positive correlation with PLK 1 mRNA(r=0 .388 ,P=0 .026;r=0 .427 ,P=0 .013) .The expression of GSK-3βprotein was high in which had high peripheral white blood cell counts ;both the expressions of GSK-3βmRNA and GSK-3βpro-tein were high in which had high risk ;but the expression of P-GSK-3βwere low .Conclusion In pediatric AML ,GSK-3βand PLK1 may play a role of oncogene and PTEN may play a role of tumor suppressor gene .